FDA
approval
· 2019-11-29
FDA Approved: TERIFLUNOMIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved a supplemental application for teriflunomide by Glenmark Pharmaceuticals Inc., USA. Teriflunomide is a disease-modifying therapy indicated for rela…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)